Gene · 6470
Papers1,819
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,819
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy. | Int J Biol Sci | 2023 | 36778122 | PubTator, text mining | PubMed |
| Phosphorylation of Thymidylate Synthase and Dihydrofolate Reductase in Cancer Cells and the Effect of CK2α Silencing. | Int J Mol Sci | 2023 | 36769342 | PubTator, text mining | PubMed |
| Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood. | Biol Psychiatry | 2023 | 36759259 | PubTator, text mining | PubMed |
| 1H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer. | Front Oncol | 2023 | 36756157 | PubTator, text mining | PubMed |
| Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. | Cell Biosci | 2023 | 36755301 | PubTator, text mining | PubMed |
| [Intervention study to inhibit the glucose metabolic remodeling in hepatocytes induced by high-selenium in vitro]. | Wei Sheng Yan Jiu | 2023 | 36750339 | PubTator, text mining | PubMed |
| [Study of high selenium interfering with glucose and one-carbon metabolism in hepatocytes in vitro]. | Wei Sheng Yan Jiu | 2023 | 36750338 | PubTator, text mining | PubMed |
| Identification of AGXT2, SHMT1, and ACO2 as important biomarkers of acute kidney injury by WGCNA. | PLoS One | 2023 | 36735737 | PubTator, text mining | PubMed |
| Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness. | Nat Metab | 2023 | 36717749 | PubTator, text mining | PubMed |
| MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway. | BMC Cancer | 2023 | 36698109 | PubTator, text mining | PubMed |
| Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition. | Sci Rep | 2023 | 36690651 | PubTator, text mining | PubMed |
| Spaceflight associated neuro-ocular syndrome: proposed pathogenesis, terrestrial analogues, and emerging countermeasures. | Br J Ophthalmol | 2023 | 36690421 | PubTator, text mining | PubMed |
| Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. | J Pers Med | 2023 | 36675817 | PubTator, text mining | PubMed |
| Gene-Folic Acid Interactions and Risk of Conotruncal Heart Defects: Results from the National Birth Defects Prevention Study. | Genes (Basel) | 2023 | 36672920 | PubTator, text mining | PubMed |
| Role of Moonlighting Proteins in Disease: Analyzing the Contribution of Canonical and Moonlighting Functions in Disease Progression. | Cells | 2023 | 36672169 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| One-carbon metabolic enzymes are regulated during cell division and make distinct contributions to the metabolome and cell cycle progression in Saccharomyces cerevisiae. | G3 (Bethesda) | 2023 | 36627750 | PubTator, text mining | PubMed |
| Metabolic reprogramming and its clinical implication for liver cancer. | Hepatology | 2023 | 36626639 | PubTator, text mining | PubMed |
| Longitudinal proteomic profiling of the inflammatory response in dengue patients. | PLoS Negl Trop Dis | 2023 | 36595532 | PubTator, text mining | PubMed |
| Widespread, Reversible Cysteine Modification by Methylglyoxal Regulates Metabolic Enzyme Function. | ACS Chem Biol | 2023 | 36562291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6470/papers?page=13